Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas

Keyphrases

• Glioblastoma 100%
• Receptor Tyrosine Kinase 100%
• In Cancer 66%
• Receptor 1 66%
• Growth Hormone Receptor 66%
• Platelet-derived Growth Factor Receptor (PDGFR) 66%
• Fibroblast Growth 66%
• Epidermal Growth Factor Receptor Inhibitors (EGFRI) 66%
• DNA Sequencing Technologies 66%
• Mutational Changes 33%
• Sequence Analysis 33%
• Intracellular Signaling 33%
• Recent Advances 33%
• Molecular Alterations 33%
• Phosphoinositide 3-kinase (PI3K) 33%
• Tyrosine Kinase 33%
• High-throughput 33%
• Neoplasia 33%
• Kinase Domain 33%
• Receptor Gene 33%
• Mitogen-activated Protein Kinase 33%
• Frameshift mutation 33%
• Coding Sequence 33%
• Cancer Genome 33%
• Kinase Gene Family 33%
• Therapeutic Interventions 33%
• Glioblastoma Brain Tumor 33%

Neuroscience

• Receptor Tyrosine Kinase 100%
• Epidermal Growth Factor Receptor 66%
• DNA Sequencing 66%
• Platelet-Derived Growth Factor Receptor 66%
• Receptor 66%
• Fibroblast 66%
• Kinase 33%
• Cell Signaling 33%
• Multigene Family 33%
• Tyrosine 33%
• Receptor Gene 33%
• Mitogen-Activated Protein Kinase 33%
• Phosphoinositide 3-Kinase 33%
• Frameshift Mutation 33%
• Intracellular Signaling 33%
• Protein Sequencing 33%
• Intracranial Tumor 33%

Biochemistry, Genetics and Molecular Biology

• Receptor Tyrosine Kinase 100%
• Epidermal Growth Factor Receptor 66%
• DNA Sequence 66%
• Platelet-Derived Growth Factor Receptor 66%
• Fibroblast 66%
• Signal Transduction 33%
• Multigene Family 33%
• Phosphoinositide 3-Kinase 33%
• Tyrosine 33%
• Intracellular Signaling 33%
• Receptor Gene 33%
• Protein Sequencing 33%
• Kinase 33%
• Phosphotransferase 33%
• Mitogen-Activated Protein Kinase 33%
• Frameshift Mutation 33%